New TB test could speed up detection of Drug-Resistant strains

NCT ID NCT05117788

Ongoing Diagnosis Sponsor: Foundation for Innovative New Diagnostics, Switzerland Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study evaluates a new PCR test (Bioneer Q-RFIA kit) for quickly and accurately detecting tuberculosis (TB) and resistance to key antibiotics. About 2,350 adults with TB symptoms will provide samples to see how well the test works compared to standard methods. The goal is to provide a single test that can guide effective treatment, especially for drug-resistant TB.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PULMONARY TUBERCULOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

multidrug-resistant tuberculosis pulmonary tuberculosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

TUBERCULOSIS, MULTIDRUG-RESISTANT

Contacts and locations

Show contact details

Locations

Centre for Infectious Disease Research in Zambia

Lusaka, Zambia
Institute of Pneumology "Chiril Draganiuc"

Chisinau, Moldova
Instituto de Medicina Tropical Alexander von Humboldt - Universidad Peruana Cayetano Heredia

Lima, Peru
KEMRI

Nairobi, Nairobi County, Kenya
V.N Karazin Kharkiv National University

Kharkiv, 61064, Ukraine